Folic acid deficiency
Drug research and approvals for folic acid deficiency: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 4 studies of folic acid deficiency are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 4
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 4 recruiting on ClinicalTrials.gov ↗
- Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD)…NCT07851025 · Phase 3 · AstraZeneca · starts Sep 16, 2026
- Folic Acid Salt Study (FISFA Zambia)NCT06734611 · Not applicable · University of Alabama at Birmingham · starts Apr 10, 2026
- Choroid Plexus Dysfunction in Neurological DiseasesNCT06403189 · Not applicable · Assistance Publique - Hôpitaux de Paris · starts Jan 20, 2025
- Patterns of Neurodevelopmental DisordersNCT06213090 · Not reported · Richard Frye · starts Feb 1, 2024
Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications
Approved 9
- Iron dextranSupplement
- Cupric sulfate
- PyridoxineSupplement
- CyanocobalaminSupplement
- Folic acid
- Niacinamide
- Riboflavin
- Zinc sulfate
- Sodium ascorbate
How its trials ended
34 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong- Completed, result not reported1956%
- Ongoing1132%
- Met its primary endpoint13%
- Missed its primary endpoint13%
- Stopped: other or unclear13%
- Status unknown13%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA